A tripyridylamide named ADH-6 was screened from an oligopyramide library to target and isolate the aggregated mutant p53 (R248W and R175H) in tumor cells and then restore the transcriptional activity of p53, resulting in cell cycle arrest and apoptosis. This evidence concerns the gene TP53 and neoplasm.